Lithuanian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
International Journal of Radiation Biology 2020-Jan

Mechanism of Asbt (Slc10a2)-Related Bile Acid Malabsorption in Diarrhea after Pelvic Radiation.

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Nuoroda įrašoma į mainų sritį
Lina Wang
Yan Zhou
Xiaohu Wang
Guangwen Zhang
Bin Guo
Xiaoming Hou
Juntao Ran
Qiuning Zhang
Chengcheng Li
Xueshan Zhao

Raktažodžiai

Santrauka

Background Radiation is a mode of treatment for many pelvic malignancies, most of which originate in the gynaecologic, gastrointestinal, and genitourinary systems. However, the healthy gut is unavoidably included in the irradiation volume, resulting in undesirable results that manifest as radiation-induced diarrhea (RID), which is the most common side effect of radiation therapy and significantly affects the patients' quality of life. This study aimed to investigate the potential mechanism of diarrhea after pelvic radiotherapy in rats based on the effect of radiation on bile acid homeostasis and sodium-dependent bile acid transporter (Asbt).Methods In this experimental study, male Sprague-Dawley rats were divided into the following groups - pelvic irradiation, cholestyramine-concurrent radiation, and control groups. The rats in the pelvic irradiation group were irradiated in the pelvic region with 2 Gy per day for 5 consecutive days. The total bile acid (TBA) levels in the ileum, colon, and feces were measured using automatic biochemical analyzer, and the levels of individual bile acids were evaluated by liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS). The mRNA and protein expression of Asbt in ileum were assessed by qRT-PCR and western blot assay. The rats in the cholestyramine-concurrent radiation group were administered with cholestyramine, a bile acid-chelating resin, and concurrent radiation for 5 days. The body weight of rats was monitored daily, and the degree of diarrhea was scored.Results Diarrhea was observed at 2 and 3 days post pelvic radiation. The TBA levels were significantly decreased at 4 and 5 days post radiation in the ileum (P < 0.01, P < 0.01) and increased at 4 and 5 days post radiation in the colon (P < 0.05, P < 0.05). The fecal excretions of TBA were significantly increased at 3, 4, and 5 days post radiation (P < 0.05). The levels of individual bile acids were significantly decreased in the ileum and increased in the colon and feces, post radiation. The mRNA and protein expression of Asbt in the ileum gradually decreased with increasing days of pelvic radiation and significantly decreased at 3 and 5 days post radiation, respectively. Furthermore, a significant decrease in body weight was observed post pelvic radiation, and cholestyramine administration did not reverse the weight loss. However, the incidence of radiation-induced diarrhea was decreased after administration of cholestyramine.Conclusions Bile acid malabsorption is partially responsible for radiation-induced diarrhea post pelvic radiation in rats, and the potential mechanism is related to the downregulation of the ileal Asbt.

Prisijunkite prie mūsų
„Facebook“ puslapio

Išsamiausia vaistinių žolelių duomenų bazė, paremta mokslu

  • Dirba 55 kalbomis
  • Žolelių gydymas, paremtas mokslu
  • Vaistažolių atpažinimas pagal vaizdą
  • Interaktyvus GPS žemėlapis - pažymėkite vaistažoles vietoje (netrukus)
  • Skaitykite mokslines publikacijas, susijusias su jūsų paieška
  • Ieškokite vaistinių žolelių pagal jų poveikį
  • Susitvarkykite savo interesus ir sekite naujienas, klinikinius tyrimus ir patentus

Įveskite simptomą ar ligą ir perskaitykite apie žoleles, kurios gali padėti, įveskite žolę ir pamatykite ligas bei simptomus, nuo kurių ji naudojama.
* Visa informacija pagrįsta paskelbtais moksliniais tyrimais

Google Play badgeApp Store badge